Acute Coronary Syndrome Market: How Is Biomarker Development...

added blog Botanik

2026-06-13 10:52:19

Acute Coronary Syndrome Market: How Is Biomarker Development Creating Risk Stratification Precision?

Biomarker development creating precision — cardiac biomarker advances enabling rapid, sensitive myocardial injury detection (high-sensitivity troponin, myoglobin) and risk stratification identifying patients with highest ischemic event risk guiding treatment intensification and resource allocation, with the Acute Coronary Syndrome Market positioned for expansion toward biomarker-driven...

0 Comments 0 Shares 74 Views 0 Reviews